Nadroparin

DRUG15 trials

Sponsors

Universitair Medisch Centrum Groningen, Onze Lieve Vrouwe Gasthuis, University Hospital, Geneva, GlaxoSmithKline, Beijing Chao Yang Hospital

Conditions

Acute Ischemic StrokeAll patients who receive ECMO treatment during the study period in one the participating centers from which (deferred) informed consent is obtained. Patients in whom the ECMO is only used to bridge a procedure like a high risk percutaneous coronary intervention or during surgery are excluded.Anticoagulants and Bleeding DisordersBypass ComplicationsCOVID-19CancerDeep Vein ThrombosisEndstage Renal Disease

Phase 2

Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures

Red Cross Hospital BeverwijkDeep Vein Thrombosis, Pulmonary Embolism

Start: 2009-04-30End: 2013-04-30Target: 669Updated: 2012-12-18

Phase 3

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

CompletedNCT00312013

GlaxoSmithKlineThrombosis, Venous

Start: 2006-05-31End: 2009-07-31Updated: 2017-03-23

A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery

CompletedNCT00843492

GlaxoSmithKlineThrombosis, Venous

Start: 2008-12-31End: 2010-06-30Updated: 2016-03-16

Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

CompletedNCT01431456

Martini Hospital GroningenVenous Thromboembolism

Start: 2013-09-30End: 2014-10-31Updated: 2018-06-07

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

RecruitingNCT04066764

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityVenous Thromboembolism

Start: 2020-05-08End: 2024-10-01Target: 200Updated: 2024-04-18

Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study

RecruitingNCT04067505

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityMay-Thurner Syndrome

Start: 2020-05-18End: 2024-12-31Target: 224Updated: 2024-04-18

Reduced anticoagulation targets in extracorporeal life support

Not yet recruitingCTIS2023-509675-16-01

Universitair Medisch Centrum GroningenAll patients who receive ECMO treatment during the study period in one the participating centers from which (deferred) informed consent is obtained. Patients in whom the ECMO is only used to bridge a procedure like a high risk percutaneous coronary intervention or during surgery are excluded.

Target: 330Updated: 2025-01-28

Phase 4

Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration

CompletedNCT00286273

Onze Lieve Vrouwe GasthuisKidney Failure, Acute

Start: 2003-03-31End: 2008-03-31Updated: 2009-08-26

Nadroparin for the Initial Treatment of Pulmonary Thromboembolism

CompletedNCT00796692

Beijing Chao Yang HospitalPulmonary Embolism, Thromboembolism, Thrombosis +1

Start: 2002-06-30End: 2006-02-28Updated: 2008-11-24

Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke

University Hospital, MartinAcute Ischemic Stroke

Start: 2013-05-31End: 2015-12-31Target: 150Updated: 2013-08-15

Prophylaxis of Venous Thromboembolism After Bariatric Surgery

Rijnstate HospitalBypass Complications, Morbid Obesity, Thromboembolism

Start: 2013-03-31End: 2015-06-30Target: 50Updated: 2014-11-20

LMWH Infusion as Anticoagulation for Home HD

Alice Ho Miu Ling Nethersole HospitalEndstage Renal Disease

Start: 2016-03-31End: 2018-05-31Target: 12Updated: 2016-11-08

Unknown Phase

Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

TerminatedNCT00303407

University Hospital, GenevaCancer, Venous Thromboembolism

Start: 2001-01-31End: 2002-07-31Updated: 2006-03-16

Nadroparin Pharmacokinetics in Different Stages of COVID-19

CompletedNCT05621915

Medical University of LublinAnticoagulants and Bleeding Disorders, COVID-19, Mechanical Ventilation +2

Start: 2021-02-01End: 2022-04-15Updated: 2022-11-18

Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT

Not yet recruitingNCT06319131

Shanghai Zhongshan HospitalPortal Vein Thrombosis

Start: 2024-05-01End: 2026-05-30Target: 84Updated: 2024-03-21

Related Papers

Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19.

2023-04-254 citations

Efficacy and safety of rivaroxaban in patients with inferior vena cava filter placement without anticoagulation contraindications (EPICT): a prospective randomised controlled trial study protocol

BMJ Open2021-10-014 citations

Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study

BMJ Open2021-01-0116 citations

An efficacy and safety study of rivaroxaban for the prevention of deep vein thrombosis in patients with left iliac vein compression treated with stent implantation (PLICTS): study protocol for a prospective randomized controlled trial.

2020-09-291 citations

Association between protein C levels and mortality in patients with advanced prostate, lung and pancreatic cancer.

2017-03-077 citations

Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below-knee plaster cast (PROTECT): A randomised controlled trial.

2017-02-2218 citations

The safety and efficacy of Heparin and Nadroparin compared to placebo in acute ischemic stroke - pilot study

Biomedical Papers2016-09-197 citations

Direct treatment comparison of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after total knee arthroplasty surgery: design of a randomised pilot study (DARINA).

2013-01-245 citations

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).

2008-12-0556 citations